Wesport Innovations inked a deal with Caterpillar this week to jointly develop natural gas engines for off-road equipment, with David Demers, Westport Innovations CEO, and Mad Money host Jim Cramer.
NYSE Euronext CEO Duncan Niederauer, discusses the Nasdaq's proposed Facebook compensation plans. "The customers are smart, I do think it will change the shape of the pipeline, and I think this illuminated the difference in the models," he says.
House Speaker John Boehner discusses President Obama's policies, the crisis in Europe and the potential fiscal cliff. "The President's policies have failed, and as a result, he has turned to the politics of envy and divide," says Boehner, and he also explains why he thinks "extending all of the current tax rates would be the first big step in the right direction."
Jim Metcalf, the CEO of Chicago-based building materials giant USG, discusses his company's latest product "UltraLight," and the relationship between his stock's success and the housing recovery.
Howard Lutnick, Cantor Fitzgerald chairman & CEO, says there is "no U.S. economy," adding that neither Ben Bernanke or President Obama have effective tools to jump-start the economy. CNBC's Tyler Mathisen, Rick Santelli & Steve Liesman weigh in.
The Facebook situation is an industry issue, says Thomas Joyce, Knight Capital CEO. "Why shouldn't a competitor get a leg up because they screwed up?" he tells CNBC's Scott Wapner.
Sean Parker, Airtime co-founder, weighs in on the controversial launch of Facebook's initial public offering, with CNBC's Andrew Ross Sorkin, and Laurence Fink, BlackRock chairman & CEO.
Lee Sachs, Alliance Partners founder & co-CEO, shares perspective on what the nation has learned from the financial crisis and what Europe can learn from it as well, with Laurence Fink, BlackRock chairman & CEO.
"Politics is playing a much more substantial role in the direction of the marketplaces." says Laurence Fink, BlackRock chairman & CEO, discussing the shape of the global markets; the strength of the U.S. economy; and making the case for investing in stocks.
"Everybody is talking about manufacturing, it doesn't matter which political party they belong to," says Jay Timmons, National Association of Manufacturers president & CEO, discussing jobs creation, politics, and restarting the U.S. economic engine.
Pebblebrook Hotel Trust is classified as a REIT, owns 21 hotels in 14 markets, and began operating at the beginning of the economy's recovery. Jon Bortz, Pebblebrook Hotel Trust CEO, discusses the state of hotel construction in the U.S. and how his company has taken advantage of the downturn in the market.
American Electric Power receives 30% of its revenues from Ohio, but the state is now deregulating the electricity market. Nick Akins, American Electric Power president & CEO, discusses his company's growth strategies moving forward and how it will face possible competition.
Shares of Mattress Firm fell 18%, and Tempur-Pedic lowered its earnings and sales guidance for both Q2 and the full year. Stephen Stagner, Mattress Firm president & CEO, discusses his company's growth strategies and why investors should not be worried.
Robert Greifeld, Nasdaq OMX Group CEO, explains what went wrong the day of the Facebook IPO. "This clearly was a low point for us," he tells CNBC's Maria Bartiromo.
In this excerpt from a "Closing Bell" live interview, Maria Bartiromo asks Nasdaq OMX Group CEO Robert Greifeld about shareholder lawsuits over how the exchange handled Facebook's IPO.
Liam McGee, chairman, president and CEO of The Hartford Financial Services Group, offers insight on the markets and his company's recent reorganization to increase shareholder returns and stock performance.
Coinstar and Starbucks have entered into an agreement to open several thousand coffee kiosks across the country. Paul Davis, CEO Coinstar, discusses with the FMHR crew.
CNBC's Becky Quick reports the latest decision on interest rates from the European Central Bank, and discussing whether the largest European banks are "too big to save," with Jim Millstein, Millstein & Company CEO and Stephen Roach, Yale University senior fellow.
Clay Siegall, Seattle Genetics president & CEO, discusses his company's latest drug developments for non-hodgkins lymphoma and hodgkins lymphoma, and its opportunity to be a "$1 billion plus product on its own."